There have been 36 insider transactions in the last 90 days previous to the date of this filing, from the activities of 7 different insiders all of which have been purchases and resulted in the acquisition of 4,355,250 company shares. In the preceding 90-day window of time, there were 18 transactions from 2 insiders which resulted in the net acquisition of 867,232 shares.
This is a lower level of transactions than the peer group average in the 150-company Pharmaceuticals peer group over the last 90-day period. Within the peer group activity averaged 36.4 transactions per company, and disposition of 6,764 shares on average.
SEC Story Link http://www.sec.gov/Archives/edgar/data/944809/000120919119041500/xslF345X03/doc4.xml
|Sector Update: Small Drop for Health Care Stocks Thi...|
|Sector Update: Tech Stocks Weighing on Broader Markets|
|Sector Update: Consumer Stocks Underpin Late Rise fo...|
|Stocks Set to Close Narrowly Mixed as Investors Awai...|
|Sector Update: Gains for Financial Stocks Helping Of...|